David Ozog
Henry Ford Health · Henry Ford Health Systems · Henry Ford Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Ozog as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:03 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05766683 · Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar LinesHenry Ford Health System · active not recruiting · Glabellar Frown Lines · principal investigator
- Ph2/Ph3NCT05478551 · Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar MinimizationHenry Ford Health System · active not recruiting · Scar, Hypertrophic Scar · principal investigator
- Ph2/Ph3NCT03887377 · The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar FormationHenry Ford Health System · completed · Scar, Hypertrophic Scar, Mammary Disorder · principal investigator
- N/ANCT00969215 · Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) LaserMoy-Fincher Medical Group · completed · Scars · principal investigator
- N/ANCT00969475 · The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound ClosureMoy-Fincher Medical Group · unknown · Scars · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:03 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser.JAMA Dermatol · 2013152 citationsRCR 8.0
- Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser.Lasers Surg Med · 2012127 citationsRCR 6.0
- Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser.Dermatol Surg · 200999 citationsRCR 4.5
- Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial.Dermatol Surg · 200990 citationsRCR 4.5
- Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser.J Am Acad Dermatol · 201078 citationsRCR 3.8
- Safety and efficacy of erbium-doped yttrium aluminum garnet fractionated laser for treatment of acne scars in type IV to VI skin.Dermatol Surg · 201066 citationsRCR 4.0
- Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.J Am Acad Dermatol · 201260 citationsRCR 2.7
- Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment.Arch Dermatol · 201150 citationsRCR 2.7
- Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression.Lasers Surg Med · 201639 citationsRCR 2.7
- Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes.J Cosmet Laser Ther · 200837 citationsRCR 1.5